Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and performance of the 23mm Portico Transcatheter Heart Valve and the TAVI Transapical Delivery System in subjects with severe symptomatic aortic stenosis


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01742598
Study type Interventional
Source Abbott Medical Devices
Contact
Status Withdrawn
Phase N/A
Start date December 2015
Completion date November 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02210351 - Evaluation of Association Between Apical Dysfunction and Trans Apical Access for TAVR, in Patients With Severe Aortic Stenosis, Undergoing Trans Apical Trans Catheter Aortic Valve Replacement (TAP-TAVR). N/A
Completed NCT02956915 - Evaluation of Length of Stay After TF-TAVI
Recruiting NCT05326126 - Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis N/A
Completed NCT04663334 - Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities
Withdrawn NCT01927601 - Assessment of Neurologic Injury Subsequent to Transcatheter Aortic Valve Replacement: A Feasibility Study N/A
Completed NCT01787084 - Alternative Access Approaches for Transcatheter Aortic Valve Replace (TAVR) in Inoperable Patients With Aortic Stenosis N/A